Current immunosuppressive treatment and self-reported lifetime stroke history among United States adults: A cross-sectional study
Muhammad Saad Ansari, Fiza Nisar, Ufaq Reyaz, Mahnoor Fatima, Umair Ahmad Khan, Baseerullah Hadi, Muhammad Talha Khalid · 2026
Read Current immunosuppressive treatment and self-reported lifetime stroke history among United States adults: A cross-sectional study by Muhammad Saad Ansari, Fiza Nisar, Ufaq Reyaz, Mahnoor Fatima, Umair Ahmad Khan, Baseerullah Hadi, Muhammad Talha Khalid (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355164.txt.
Description
Muhammad Saad Ansari is first author on a 2026 PLOS ONE national survey study of immune-suppressing treatment and stroke in United States adults. Such drugs treat autoimmune, inflammatory, cancer, and transplant conditions that may carry high stroke burden. National evidence linking current use to lifetime stroke history was limited.
Pooling two years of a national health interview survey gave sixty thousand adults, representing about two hundred and fifty million people. Stroke history was reported by six percent of those on immune-weakening drugs, against under three percent of others. The link held after adjusting for age, blood pressure, diabetes, and other factors. The authors stress the design shows association, not cause.
Catalog record
| CREATOR | Muhammad Saad Ansari, Fiza Nisar, Ufaq Reyaz, Mahnoor Fatima, Umair Ahmad Khan, Baseerullah Hadi, Muhammad Talha Khalid |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27127 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |